Company News
To keep up to date about Check-Points, subscribe to our newsletter.
Symposium: Molecular detection of ESBL and carbapenemases
Jan 30, 2012
On the 13th of March 2012 we will organize our first symposium, "Molecular detection of ESBL and carbapenemases: now and in the future", in Utrecht, The Netherlands.
Visit our booth at ICAAC in Chicago 17-19 September
Sep 14, 2011
Learn more about our solutions to detect multidrug resistance in Gram-negative bacteria - at booth #716.
Introducing the Check-MDR CT103
Jun 08, 2011
Detect the clinically prevalent carbapenemases, ESBLs and AmpCs - in a single test.
Meet us at ECCMID in Milan 7-10 May!
Apr 14, 2011
Learn more about our latest products in booth 434.
Combat drug resistance - no action today, no cure tomorrow
Apr 07, 2011
April 7 is World Health Day. The theme this year is "Combat Drug Resistance - no action today, no cure tomorrow". But is tomorrow already here?
Check-Points at the Scientific Spring Meeting of the Dutch Microbiological Societies,18-20 April
Apr 01, 2011
Meet us at booth 36 and learn more about our latest solutions for the detection of Gram-negative antibiotic resistance.
Is ESBL in poultry linked to ESBL in humans?
Mar 16, 2011
A study by Leverstein-van Hall et al. to be published in Clinical Microbiology and Infection found 35% of human ESBL genes to be the same as those found in poultry.
Evaluation of Check-MDR CT102 published in Journal of Clinical Microbiology
Feb 18, 2011
Check-MDR CT102, which detects carbapenemases as well as ESBLs, was found to have a sensitivity and specificity of 100%.
Check-Points Salmonella assay obtains AOAC-RI certification
Jan 14, 2011
The Premi Test Salmonella is a unique microarray-based product for confirmation and serotyping of Salmonella.
